These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25273027)

  • 1. Antitumor activity of DMAKO-05, a novel shikonin derivative, and its metabolism in rat liver microsome.
    Zhang X; Wang RB; Zhou W; Xiao S; Meng QQ; Li SS
    AAPS PharmSciTech; 2015 Apr; 16(2):259-66. PubMed ID: 25273027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMAKO-20 as a New Multitarget Anticancer Prodrug Activated by the Tumor Specific CYP1B1 Enzyme.
    Cui J; Zhang X; Huang G; Zhang Q; Dong J; Sun G; Meng Q; Li S
    Mol Pharm; 2019 Jan; 16(1):409-421. PubMed ID: 30481041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shikonin Derivative DMAKO-05 Inhibits Akt Signal Activation and Melanoma Proliferation.
    Yang YY; He HQ; Cui JH; Nie YJ; Wu YX; Wang R; Wang G; Zheng JN; Ye RD; Wu Q; Li SS; Qian F
    Chem Biol Drug Des; 2016 Jun; 87(6):895-904. PubMed ID: 26804061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Antitumor Effect of Shikonin Derived DMAKO-20 on Melanoma through CYP1B1.
    Cui J; Zhou X; Huang J; Cui J; Chen J
    Curr Cancer Drug Targets; 2020 Nov; ():. PubMed ID: 33200710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach.
    Wang RB; Zhou W; Meng QQ; Zhang X; Ding J; Xu Y; Song HL; Yang K; Cui JH; Li SS
    ChemMedChem; 2014 Dec; 9(12):2798-808. PubMed ID: 25234005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of shikonin on the metabolism of lapatinib in vitro, and in vivo.
    Hu Y; Xie S; Xia H; Chen J; Yang Y; Zhan R
    Toxicol Appl Pharmacol; 2024 Jan; 482():116797. PubMed ID: 38160892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory Effects and Mechanisms of the Novel Shikonin Derivative DMAKO-20 on Melanoma Metastasis and Invasion.
    Zhou X; Huang J; Liu S; Cui J; Chen J
    Discov Med; 2024 Jun; 36(185):1231-1240. PubMed ID: 38926109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of methoxymorpholinyl doxorubicin: potentiation by cytochrome P450 3A metabolism.
    Lu H; Waxman DJ
    Mol Pharmacol; 2005 Jan; 67(1):212-9. PubMed ID: 15465924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on in vitro metabolism of shikonin.
    Li H; Luo S; Zhou T
    Phytother Res; 1999 May; 13(3):236-8. PubMed ID: 10353167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of 1-naphthol by rat liver microsomes to 1,4-naphthoquinone and covalent binding species.
    Doherty MD; Cohen GM
    Biochem Pharmacol; 1984 Oct; 33(20):3201-8. PubMed ID: 6487366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effects of shikonin and β,β-dimethylacrylshikonin on tramadol metabolism in vitro and in vivo.
    Jin M; Shi D; Jin H; Zhou Z; Wang C
    J Pharm Pharmacol; 2020 Sep; 72(9):1232-1238. PubMed ID: 32424860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of Novel Shikonin Glucosides by Enzymatic Glycosylation.
    Li B; Zhu M; Ma H; Ma T; Dai Y; Li H; Li Y; Wu CZ
    Chem Pharm Bull (Tokyo); 2019; 67(10):1072-1075. PubMed ID: 31582627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the inhibition risk of shikonin on cytochrome P450 via cocktail inhibition assay.
    Tang S; Chen A; Zhou X; Zeng L; Liu M; Wang X
    Toxicol Lett; 2017 Nov; 281():74-83. PubMed ID: 28941798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans--toxicological implications.
    Shindoh H; Nakano K; Yoshida T; Ishigai M
    J Toxicol Sci; 2011 Aug; 36(4):411-22. PubMed ID: 21804305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism studies of the anti-tumor agent maytansine and its analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry.
    Liu Z; Floss HG; Cassady JM; Chan KK
    J Mass Spectrom; 2005 Mar; 40(3):389-99. PubMed ID: 15674857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of new-generation taxanes in human, pig, minipig and rat liver microsomes.
    Gut I; Ojima I; Vaclavikova R; Simek P; Horsky S; Linhart I; Soucek P; Kondrova E; Kuznetsova LV; Chen J
    Xenobiotica; 2006 Sep; 36(9):772-92. PubMed ID: 16971343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of dacarbazine by rat liver microsomes contribution of CYP1A enzymes to dacarbazine N-demethylation.
    Yamagata S; Ohmori S; Suzuki N; Yoshino M; Hino M; Ishii I; Kitada M
    Drug Metab Dispos; 1998 Apr; 26(4):379-82. PubMed ID: 9531528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.
    Komatsu T; Yamazaki H; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2000 Dec; 28(12):1457-63. PubMed ID: 11095583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.
    Zhang X; Zhong JL; Liu W; Gao Z; Xue X; Yue P; Wang L; Zhao C; Xu W; Qu X
    Cancer Chemother Pharmacol; 2010 May; 66(1):11-9. PubMed ID: 19756602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat cytochrome p450 1A and 3A enzymes involved in bioactivation of tegafur to 5-fluorouracil and autoinduced by tegafur in liver microsomes.
    Yamazaki H; Komatsu T; Takemoto K; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Jun; 29(6):794-7. PubMed ID: 11353746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.